Screener
BioCryst Pharmaceuticals BCRX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $156.38M+73.9% | $173.38M+62.2% | $91.34M-14.1% | $84.08M-13.2% | $89.93M+14.7% | ||
| $197.6M+14.9% | $66.81M-64.8% | $185.01M-14.4% | $128.8M-44.8% | $172.01M-11.2% | ||
| $31.95M+43.9% | $28.18M+12.3% | $23.99M+3.5% | $23.39M+8.1% | $22.21M-9.5% | ||
| $484.68M+21.6% | $373.63M-8.9% | $404.35M-4.2% | $355.68M-16.7% | $398.46M+9.6% | ||
| $9.06M+7.1% | $9.37M+23.4% | $8.78M+12.9% | $8.4M+13.1% | $8.46M+10.4% | ||
| $557.85M+22.0% | $465.05M-3.1% | $514.16M+4.8% | $446.42M-9.1% | $457.19M-3.2% | ||
| $11.46M+33.4% | $10.96M+9.0% | $15.83M+35.9% | $5.57M-58.7% | $8.59M+10.3% | ||
| $12.32M— | $5.41M— | $0— | —— | —— | ||
| $1.09M-32.4% | $1.24M-31.2% | $1.31M-28.5% | $1.44M-22.0% | $1.62M-3.9% | ||
| $208.85M+17.9% | $195.39M+39.7% | $196.07M+22.2% | $190.24M+23.9% | $177.16M+37.3% | ||
| $395.4M+62.9% | $395.2M+25.3% | $0-100% | $194.37M-38.2% | $242.79M-22.6% | ||
| $1.01B+15.2% | $1.02B+9.3% | $633.31M-34.5% | $834.31M-13.1% | $878.78M— | ||
| 450M0.0% | 450M0.0% | 450M+21,483% | 450M0.0% | 450M0.0% | ||
| -$2.15B-21.8% | -$2.23B-25.9% | -$1.51B+14.9% | -$1.75B-0.5% | -$1.76B-2.1% | ||
| -$454.29M-7.8% | -$553.84M-22.6% | -$119.15M+75.0% | -$387.89M+17.2% | -$421.59M+11.4% | ||
| $557.85M+22.0% | $465.05M-3.1% | $514.16M+4.8% | $446.42M-9.1% | $457.19M-3.2% |
FAQ
- What are BioCryst Pharmaceuticals's total assets?
- BioCryst Pharmaceuticals (BCRX) holds $557.9M in total assets, up 22.0% year over year.
- How much debt does BioCryst Pharmaceuticals have?
- BioCryst Pharmaceuticals carries $410.9M in total debt against -$454.3M of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does BioCryst Pharmaceuticals have?
- BioCryst Pharmaceuticals holds $156.4M in cash and equivalents.
- Can BioCryst Pharmaceuticals cover its short-term obligations?
- Its current ratio is 2.32 — current assets exceed current liabilities.
- Where does BioCryst Pharmaceuticals's balance sheet data come from?
- Every line is extracted from BioCryst Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
